IMNN IMUNON INC revenue, earnings and financials
For the quarter ended June 30, 2026, IMUNON INC reported revenue of n/a, net income of −$2.81M and diluted EPS of −$0.54; for the fiscal year ended December 2025 revenue was n/a.
IMNN annual revenue and earnings
- Fiscal year ended Dec 2025: revenue n/a, gross profit n/a, operating income −$14.7M, net income $14.5M (margin n/a), EPS −$6.83
- Fiscal year ended Dec 2024: revenue n/a, gross profit n/a, operating income −$19.1M, net income −$18.6M (margin n/a), EPS −$16.94
- Fiscal year ended Dec 2023: revenue n/a, gross profit n/a, operating income −$21.0M, net income −$19.5M (margin n/a), EPS −$2.16
- Fiscal year ended Dec 2022: revenue $500K, gross profit n/a, operating income −$24.9M, net income −$35.9M (margin -7179.6%), EPS −$5.03
- Fiscal year ended Dec 2021: revenue $500K, gross profit n/a, operating income −$21.0M, net income −$20.8M (margin -4153.9%), EPS −$3.83
IMNN quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$2.81M, EPS −$0.54
- Quarter ended Mar 31, 2026: revenue n/a, net income −$4.25M, EPS −$0.84
- Quarter ended Dec 31, 2025 (from the annual report): revenue n/a, net income $24.8M, EPS −$0.37
- Quarter ended Sep 30, 2025: revenue n/a, net income −$3.43M, EPS −$1.16
- Quarter ended Jun 30, 2025: revenue n/a, net income −$2.74M, EPS −$2.15
- Quarter ended Mar 31, 2025: revenue n/a, net income −$4.10M, EPS −$3.15
- Quarter ended Dec 31, 2024 (from the annual report): revenue n/a, net income −$4.06M, EPS −$5.02
- Quarter ended Sep 30, 2024: revenue n/a, net income −$4.85M, EPS −$3.76
- Quarter ended Jun 30, 2024: revenue n/a, net income −$4.79M, EPS −$7.64
- Quarter ended Mar 31, 2024: revenue n/a, net income −$4.93M, EPS −$0.52
- Quarter ended Dec 31, 2023 (from the annual report): revenue n/a, net income −$4.89M, EPS −$0.50
- Quarter ended Sep 30, 2023: revenue n/a, net income −$3.48M, EPS −$0.37
- Quarter ended Jun 30, 2023: revenue n/a, net income −$5.56M, EPS −$0.61
- Quarter ended Mar 31, 2023: revenue n/a, net income −$5.59M, EPS −$0.68
- Quarter ended Dec 31, 2022 (from the annual report): revenue $125K (up 0.0% year over year), net income −$13.2M, EPS n/a
- Quarter ended Sep 30, 2022: revenue $125K (up 0.0% year over year), net income −$6.15M, EPS −$0.87
- Quarter ended Jun 30, 2022: revenue $125K (up 0.0% year over year), net income −$6.04M, EPS −$0.87
- Quarter ended Mar 31, 2022: revenue $125K (up 0.0% year over year), net income −$10.5M, EPS n/a
- Quarter ended Dec 31, 2021 (from the annual report): revenue $125K, net income −$4.22M, EPS −$3.62
- Quarter ended Sep 30, 2021: revenue $125K, net income −$5.41M, EPS −$0.06
IMNN cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$13.9M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$18.9M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$19.0M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$23.1M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$16.2M, share buybacks n/a
IMNN balance sheet
- Jun 30, 2026: cash $6.86M, total assets $15.0M, total liabilities $10.8M, shareholders' equity $4.19M
- Mar 31, 2026: cash $4.79M, total assets $8.02M, total liabilities $4.66M, shareholders' equity $3.36M
- Dec 31, 2025: cash $8.78M, total assets $12.3M, total liabilities $5.23M, shareholders' equity $7.06M
- Sep 30, 2025: cash $5.25M, total assets $8.99M, total liabilities $4.91M, shareholders' equity $4.08M
- Jun 30, 2025: cash $4.73M, total assets $8.79M, total liabilities $6.13M, shareholders' equity $2.66M
- Mar 31, 2025: cash $2.87M, total assets $6.86M, total liabilities $6.41M, shareholders' equity $452K
- Dec 31, 2024: cash $5.87M, total assets $9.72M, total liabilities $5.47M, shareholders' equity $4.24M
- Sep 30, 2024: cash $10.3M, total assets $14.4M, total liabilities $6.20M, shareholders' equity $8.19M
Is IMNN profitable?
Yes. IMUNON INC earned $14.3M over the last four quarters.
What is IMNN's EPS?
Diluted earnings per share over the last four quarters were −$2.91; −$0.54 in the latest quarter.